Dysfunctional Telomeres, Checkpoints and Aging
功能失调的端粒、检查点和衰老
基本信息
- 批准号:7653672
- 负责人:
- 金额:$ 26.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-30 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAgeAgingAging-Related ProcessAllelesApoptosisAutopsyBiologicalBiological ModelsBreedingCell AgingCell Culture TechniquesCell DeathCell divisionCellsChickensChromosomal RearrangementChromosomesComplexDNADataDoctor of MedicineDoctor of PhilosophyEngineeringEventFailureFunctional disorderGene DosageGenerationsGenesGeneticGenomeGenome StabilityGenomic InstabilityGenotypeHistocompatibility TestingHomeostasisIn VitroIncidenceLengthLightLinkLongevityMalignant NeoplasmsModelingMolecularMolecular CytogeneticsMolecular GeneticsMusMutant Strains MiceMutationOrganOrgan failureOxidative StressPathologicPathway interactionsPhenotypePhysiologicalPlayPopulationPremature aging syndromePreventionProcessReadingReserve Stem CellRoleSeriesSignal TransductionStagingStem cellsStructureTP53 geneTamoxifenTelomeraseTelomere MaintenanceTelomere ShorteningTestingTherapeutic InterventionTimeTissuesTumor SuppressionUpper armWorkanimal tissuebasebeta Actinbody systemcancer genomecarcinogenesiscell typecellular targetingcohortexhaustin vivoinsightmouse modelmutantmutant mouse modelpreventreconstitutionresponsesenescencestemtelomeretumor progressiontumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Telomeres are specialized capping structures on chromosomes that play important roles in aging, cancer and genome stability. With each cell division, telomeres progressively shorten such that upon reaching a critical stage, they signal cells to stop dividing. This process likely prevents cells from acquiring mutations that may result in cancer or aging. When mutations occur in crucial genes that regulate telomere maintenance or checkpoint responses (such as p53 and ATM), telomeres become critically shortened and dysfunctional. Our recent findings linking telomere dysfunction to precursor/stem cell depletion and accelerated aging in the combined telomerase Atm mutant mouse model provide a unique opportunity and genetic platform to explore the molecular mechanisms by which telomere dysfunction contributes to aging, organ homeostasis and tumorigenesis. We hypothesize that mice engineered to have critically short telomeres and defective checkpoint responses due to mTerc and Atm deficiency will be predisposed to either accelerated aging or tumorigenesis depending on p53 status. We also believe that reconstitution of telomerase activity in different organ compartments of these mice will, depending on the state of the genome at the time of the reconstitution, either strongly promote organ specific tumor progression or rescue the organ stem/progenitor cell depletion phenotype as well as suppressing tumorigenesis. Lastly, detailed molecular characterization of pathways leading to activation of p53 function in primary cells and tissues from these compound mutant mice with accelerated aging and precursor/stem cell depletion will dissect the molecular pathways that are involved in the process of aging and organ homeostasis.
描述(由申请人提供):端粒是染色体上的专门的加帽结构,在衰老、癌症和基因组稳定性中起重要作用。随着每一次细胞分裂,端粒逐渐缩短,以至于在达到关键阶段时,它们向细胞发出停止分裂的信号。这个过程可能会阻止细胞获得可能导致癌症或衰老的突变。当调节端粒维持或检查点反应的关键基因(如p53和ATM)发生突变时,端粒会严重缩短并功能失调。我们最近的研究结果将端粒功能障碍与前体/干细胞耗竭和联合端粒酶Atm突变小鼠模型中的加速衰老联系起来,这为探索端粒功能障碍导致衰老、器官稳态和肿瘤发生的分子机制提供了独特的机会和遗传平台。我们假设,由于mTerc和Atm缺陷而被设计为具有严重短端粒和缺陷检查点反应的小鼠将倾向于加速衰老或肿瘤发生,这取决于p53状态。我们还相信,根据重建时基因组的状态,这些小鼠不同器官区室中端粒酶活性的重建将强烈促进器官特异性肿瘤进展或拯救器官干/祖细胞耗竭表型以及抑制肿瘤发生。最后,详细的分子表征的途径,导致激活p53功能的原代细胞和组织从这些化合物突变小鼠加速老化和前体/干细胞耗竭将解剖的分子途径,参与衰老和器官稳态的过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kwok Kin Wong其他文献
Kwok Kin Wong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kwok Kin Wong', 18)}}的其他基金
Therapeutic strategies for specific subsets of KRAS mutant lung cancers
KRAS 突变肺癌特定亚型的治疗策略
- 批准号:
9451116 - 财政年份:2017
- 资助金额:
$ 26.99万 - 项目类别:
Core C: Animal Modeling and Preclinical Therapeutics
核心 C:动物建模和临床前治疗
- 批准号:
10231104 - 财政年份:2012
- 资助金额:
$ 26.99万 - 项目类别:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
EGFR 突变驱动的肺癌对放射治疗反应的体内分析
- 批准号:
8450878 - 财政年份:2006
- 资助金额:
$ 26.99万 - 项目类别:
In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap
EGFR 突变驱动的肺癌对放射治疗反应的体内分析
- 批准号:
8826566 - 财政年份:2006
- 资助金额:
$ 26.99万 - 项目类别:
Dysfunctional Telomeres, Checkpoints and Aging
功能失调的端粒、检查点和衰老
- 批准号:
7484951 - 财政年份:2006
- 资助金额:
$ 26.99万 - 项目类别:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
肿瘤发生中的 EGFRvIII 突变和对酪氨酸激酶抑制剂的敏感性
- 批准号:
7428779 - 财政年份:2006
- 资助金额:
$ 26.99万 - 项目类别:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
肿瘤发生中的 EGFRvIII 突变和对酪氨酸激酶抑制剂的敏感性
- 批准号:
7269241 - 财政年份:2006
- 资助金额:
$ 26.99万 - 项目类别:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
肿瘤发生中的 EGFRvIII 突变和对酪氨酸激酶抑制剂的敏感性
- 批准号:
7130431 - 财政年份:2006
- 资助金额:
$ 26.99万 - 项目类别:
EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors
肿瘤发生中的 EGFRvIII 突变和对酪氨酸激酶抑制剂的敏感性
- 批准号:
7837568 - 财政年份:2006
- 资助金额:
$ 26.99万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 26.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 26.99万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 26.99万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 26.99万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 26.99万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 26.99万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 26.99万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 26.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 26.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 26.99万 - 项目类别:
Operating Grants